Elanco Animal Health Inc (ELAN)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
$11.73
Buy
$12.95
$-0.02 (-0.15%)
Prices updated at 16 May 2025, 23:22 EDT
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Lawrence E. Kurzius
CEO
Mr. Jeffrey N. Simmons
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
9,450
Head office
2500 Innovation Way
Greenfield
United States
46140
Key personnel
Owner name | Salary |
---|---|
Mr. John P. Bilbrey Independent Director | 0.11m |
Ms. Kathy V. Turner Independent Director | 0.07m |
Mr. Craig Wallace Independent Director | 0.07m |
Mr. Art A. Garcia Independent Director | 0.09m |
Dr. Deborah T. Kochevar, D.V.M.,PhD Independent Director | 0.11m |
Mr. Lawrence E. Kurzius Chairman of the Board | 0.19m |
Mr. R. David Hoover Independent Director | 0.16m |
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director | 1.20m |
Mr. Paul S. Herendeen Independent Director | 0.09m |
Mr. Michael J. Harrington Independent Director | 0.10m |
Dr. Denise Vera Scots-Knight, PhD Independent Director | 0.09m |
Ms. Kapila Kapur Anand Independent Director | 0.12m |
Mr. Todd S. Young Executive Vice President and Chief Financial Officer | 0.69m |
Mr. David S. Kinard Executive Vice President, Human Resources, Corporate Communications and Administration | - |
Mr. Ramiro Martin Cabral Executive Vice President and President of Elanco International | 0.62m |
Mr. James M. Meer Senior Vice President and Chief Accounting Officer | - |
Mr. Kirk McDonald Independent Director | 0.10m |
Mr. Timothy J. Bettington Executive Vice President, Corporate Strategy and Market Development | 0.64m |
Mr. Jose Manuel Correia de Simas, PhD Executive Vice President, U.S. Farm Animal Business | - |
Dr. Stacey Ma, PhD Independent Director | 0.01m |
Ms. Ellen de Brabander, PhD Executive Vice President, Innovation and Regulatory Affairs | 0.75m |
Mr. Rajeev A. Modi Executive Vice President, U.S. Pet Health and Global Digital Transformation | - |
Ms. Grace McArdle Executive Vice President, Manufacturing and Quality | - |
Ms. Shiv O'Neill Executive Vice President, General Counsel and Corporate Secretary | - |
Top 5 shareholders
Owner name | No. of shares |
---|---|
Dodge & Cox | 82,920,582 |
Dodge & Cox Stock Fund | 55,341,300 |
FMR Inc | 53,858,673 |
Fidelity Management and Research Company | 53,858,673 |
PRIMECAP Management Company | 50,223,535 |
Director dealings
Date | Action |
---|---|
31 Dec 2024 | - |
27 Dec 2024 | - |
27 Dec 2024 | - |
13 Dec 2024 | - |
13 Dec 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
29 Nov 2024 | - |
15 Nov 2024 | - |
15 Nov 2024 | - |
Please note that past performance is not a reliable indicator of future returns.